LUMOS PHARMA, INC. 3 SEC Filings

Filed On	Filing
10 Jan 2024	Form 3: Pitukcheewanont Pisit Duke, Chief Medical Officer Holds 10,930 shares of Common Stock
02 Sep 2021	Form 3: Karpf David B, Chief Medical Officer Holds 7,500 shares of Common Stock
28 May 2021	Form 3: Schuchart Aaron, Chief Business Officer Holds 928 shares of Common Stock
18 Feb 2021	Form 3: van Es-Johansson An, Director Holds 733 shares of Common Stock
30 Mar 2020	Form 3: Hawkins Richard J, Director Holds 719,575 shares of Common Stock
30 Mar 2020	Form 3: McKew John C., Chief Scientific Officer
30 Mar 2020	Form 3: McCracken Joseph S, Director No securities owned
30 Mar 2020	Form 3: Lalande Kevin M., Director Holds 409,627 shares of Common Stock
30 Mar 2020	Form 3: Cunningham Emmett, Director No securities owned
20 Mar 2020	Form 3: Flynn James E, 10% owner and 3 others Holds 936,169 shares of Common Stock
12 Aug 2019	Form 3: Powers Bradley J, Principal Executive Officer Holds 579 shares of Common Stock
03 Aug 2018	Form 3: Lawley Lori D, Principal Accounting Officer Holds 1,526 shares of Common Stock
01 May 2018	Form 3: Sherman Matthew L, Director
21 Mar 2018	Form 3: Johnson Chad Allen, Director
22 Nov 2017	Form 3: Kennedy Eugene P., Chief Medical Officer Holds 14,077 shares of Common Stock
16 Nov 2015	Form 3: Pucci Paolo, Director Holds 6,170 shares of Common Stock
03 Oct 2014	Form 3: Henneman John B Iii, EVP, Chief Financial Officer No securities owned
18 Nov 2013	Form 3: Langren Carl W., Principal Accounting Officer Holds 56,991 shares of Common Stock
14 Jan 2013	Form 3: Wiley Brian, VP of Business Development Holds 0 shares of Common Stock
06 Nov 2012	Form 3: Zoth Lota S., Director

Comments